Gastroenterology Flashcards
Fibrosis in the liver is caused by which inflammatory cell?
Stellate cell
3 ways of diagnosing liver cirrhosis
Liver biopsy
Fibroscan
MRI-E
5 parameters in the Child Pugh score
- Bilirubin
- Albumin
- Ascites
- Encephalopathy
- INR
Mortality risk score in cirrhosis
MELD score - Uses creatinine, Bilirubin and INR.
What is the SAAG score and its cut off
Serum albumin: Ascites albumin.
>11 = portal hypertension (transudative)
Medical management of ascites
- Spironolactone
- Frusemide
- Low salt diet
- Albumin
Role of Rifaximin
Reduced encephalopathy
Management of variceal bleeding
- Antibiotics - Ceftriaxone or Norfloxacin
- Octerotide or Teripressin (to vasocontrict Splanchnic circulation)
- Variceal banding/ Glue injection/ Balloon Tamponade
- TIPS
Blood pressure aim in variceal bleeding
SBP 90
Hb Aim in variceal bleeding
Hb 70
MOA of Octreotide
Somatostatin analogue
- decreases glucagon to decrease splanchnic vasodilation
- decreases gastric acid production
MOA of Terlipressin in UGI bleeds
Vasoconstricts splanchnic circulation
Management of stage 2 and 3 HCC
TACE + Sorafenib/Levatinib (multi-kinase inhibitors)
What percentage of adults exposed to Hep B develop chronic infection?
5%
Hep B e Antigen positive indicates:
Active viral replication
Fibroscan is only diagnostic for what stages?
Stage 1 - cirrhosis ruled out
Stage 4 - cirrhosis ruled in
When is Hep B treated?
During Clearance and Escape phase.
Rising ALT = development of fibrosis
Hep B treatment
Entecavir
Tenofovir
Hep B treatment in pregnancy + birth
Use tenofovir for treatment of mum
Immunoglobulin and Vaccination to baby
Endoscopic management of peptic ulcer disease
INJECT adrenaline + CLIP or CAUTERIZE
Ulcerative Colitis histological features:
Lymphocytes+ Goblet cell depletion + crypt distortion/ abscesses.
Crohn’s histological features
Granulomas
Transmural
IBD high risk genes
NOD2/CARD 15
Marker used for monitoring IBD disease activity
Faecal calprotectin
Initial therapy Crohn’s Disease
Corticosteroids + AZA/6MP/MTX
Initial therapy UC
Corticosteroids + AZA/6MP/MTX/5ASA
Management of refractory disease in IBD
- Infliximab/Adalimumab
- Vedolizumab/Ustekinumab
Rescue therapy in UC only - Cyclosporine
Drug which reduces risk of colorectal cancer in UC
Sulfasalazine/Mesalazine (5ASAs)
MOA of Thiopurines
Inhibit purine synthesis
Inhibit Tcell and Bcell proliferation
Induce T cell apoptosis
Why do we measure TMPT levels
High TPMT means increased shunting to inactive 6MMP metabolite.
Low TPMT means increased 6-TGN active metabolite which increases the risk of myelotoxicity.
Interaction of Thiopurines and Allopurinol
Allopurinol blocks Xanthine Oxidase pathway –> Increased shunting to active 6-TNG metabolite.
MOA of Cyclosporine
Calcineurin Inhibitor. Blocks synthesis of IL-2 in T-cells.
Steroid of choice in UC
Budesonide
Vedolizumab MOA
a4b7 integrin inhibitor. Gut specific.
Blocks T lymphocytes interacting with intestinal endothelium MAdCAM–1 cells.
Note: Works on T lymphocytes, not on intestinal cells.
MOA Ustekinumab
IL-12 and IL-23 inhibitor
Crohn’s 1 year risk of recurrence post bowel resection
80%
Drug which improves the histological features of NASH
Pioglitazone
Inheritance of Hereditary Hemochromatosis
Autosomal recessive
Complications of Hereditary Hemochromatosis
- cirrhosis
- HCC
- Diabetes
- Cardiomyopathy
Management of Hereditary Hemochromatosis
- Phlebotomy ONLY if ferritin >400 or iron deposition tissue injury. (Iron chelation NOT used)
Changes in starvation
- Ketosis
- Proteolysis
- Pancytopenia
- Electrolyte loss
- Reduced hypothalamic hormones
- Cardiac dysfunction/arrythmias
Mechanism of re-feeding.
Over-shoot of insulin to carbohydrate load.
Leads to K, Mg, PO4 moving intracellularly.
Increased salt retention = oedema
Increased risk of which type of gall stone in bowel resection
oxalate stone.
Management of short gut
- Electrolyte supplementation
- Vit B, C supplementation
- PPI/ octreotide to reduce GI secretions
- Imodium/Codeine to slow transit.
- Pancreatic enzymes
- Dry meals
- Teduglutide
MOA of Teduglutide
a GLP-2 analogue. Promotes mucosal growth
Antibodies for Coeliac disease - and which are most specific.
- Tissue transglutaminase (TTG) antibody
- IgA endomysial antibodies
- Deaminated gliadin peptide (DGP) antibody
EMA and TTG most specific
Histological findings in coeliac disease
Villous atrophy
Crypt hyperplasia
Increased lymphocytes
Rule out genetic tests for Coeliac disease
HLADQ2
HLADQ8
MOst common Hep C genotype in Australia
Type 3
Other Hepatitis C manifestations
Cryoglobulinemia
Membranoproliferative GN
Porphyria cutanea Tarda
Hepatitis cancer screening schedule
6 monthly liver US and AFP
Variceal bleed prophylaxis
Beta-blockers - propanolol/ carvidelol
OR
Banding
Pathophysiology of Hepatorenal syndrome.
Arterial vasodilatation in the splanchnic circulation, which is triggered by portal hypertension, causes progressive rise in cardiac output and fall in systemic vascular resistance. This leads to renal hypoperfusion and AKI. Bacterial translocation may play a role.
Hepatorenal Syndrome types
HRS-AKI Type 1 - Atleast 2x increase in serum creatinine in 2 weeks.
HRS-AKI Type 2 - Less than 2x increase in serum creatinine. < 90days.
HRS-CKD - eGFR <60 for >3 months with no other cause.
HCC transplant criteria - nodule size and number
<3 nodules <4.5cm (or 6.5 if only 1)
Assessment of oesophageal motility/ dysphagia
Manometry
Gastroscope
Management of oesophageal spasm
soft food, PPI, GTN, Ca Channel blockers, botox, dilatation
Endoscopic findings in eosinophilic oesophagitis
exudate rings
furrows
Management of eosinophilic oesophagitis
PPI fluticasone puffer budesonide slurry dilatation if stricturing Food elimination diet
Pathophys of Achalasia
Lower oesophageal sphincter unable to relax
Manometry and Barium swallow findings in achalasia
Pressure wave contractions
Aperistalsis
Steeple/birds beak appearance
Management of Achalasia
Botox Balloon dilatation Ca channel blockers, GTN POEMS procedure surgical myotomy
Drugs causing transaminitis
Drugs causing mixed picture
Drugs causing cholestatic picture
Drugs causing transaminitis
- Paracetamol, statins, Isoniazid.
Drugs causing mixed picture
- Anti-epileptics - Carbamazepine, Phenytoin, Lamotrigine.
Drugs causing cholestatic picture
- Abx - flucloxacillin, Amoxycillin, Cephalosporins.
Causes of severe transaminitis
Ischaemic hepatitis, Viral hepatitis, Paracetamol, Thrombosis.
Pathophys of EtOH withdrawal.
EtOH is a CNS depressant. Therefore there is compensatory upregulation of GABA, glutamate and NMDA receptors with time. Cessation of EtOH unmasks CNS upregulation.
AST:ALT >2 = ?
Alcoholic hepatitis
Note: mortality benefit with prednisolone.